chronic lymphocytic leukemia
If there's one thing that proponents of "integrative medicine" (or, as it's been called in the past, "complementary and alternative medicine," or CAM) take great pains to emphasize whenever defending their integration of prescientific and pseudoscientific medicine into medicine, it's that they do not recommend using "alternative medicine" instead of real medicine but in addition to real medicine. Indeed, even the "gods" of integrative medicine, such as Barrie Cassileth at Memorial Sloan-Kettering Cancer Center, not only emphasize that but actually often take umbrage when it is suggested that…
Last month, Penn Medicine put out a press release heralding a "cancer treatment breakthrough 20 years in the making." In a small clinical trial, three patients with advanced chronic lymphocytic leukemia (CLL) were treated with genetically engineered versions of their own T cells. Just a few weeks after treatment the tumors had disappeared, and the patients remained in remission for a year before the study was published.
The release didn't, however, explain those "20 years in the making." In 1989, Prof. Zelig Eshhar of the Weizmann Institute's Immunology Department first published a paper…